✦ LIBER ✦
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma
✍ Scribed by Satoru Hagiwara; Masatoshi Kudo; Kazuomi Ueshima; Hobyung Chung; Mami Yamaguchi; Masahiro Takita; Seiji Haji; Masatomo Kimura; Tokuzo Arao; Kazuto Nishio; Ah-Mee Park; Hiroshi Munakata
- Publisher
- Springer Japan
- Year
- 2010
- Tongue
- English
- Weight
- 319 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.